Efficacy of 5 Years of Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B Patients With High Viral Load (HBV DNA ≥9 Log10 Copies/Ml)

被引：0
|
作者：
Gordon, Stuart C.
Marcellin, Patrick
Krastev, Zahary
Horban, Andrzej
Petersen, Joerg
Sperl, Jan
Phillip Dinh
Martins, Eduardo B.
Yee, Leland J.
Flaherty, John F.
Kitrinos, Kathryn M.
Rustgi, Nika Berger Vinod K.
Heathcote, Jenny
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S954 / S954
页数：1
相关论文
共 50 条
  • [41] 48-WEEK SAFETY AND EFFICACY OF SWITCHING TO TENOFOVIR ALAFENAMIDE (TAF) FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HBV ASIAN PATIENTS WITH TDF RISK FACTORS (RF)
    Ahn, Sang Hoon
    Kao, Jia-Horng
    Hann, Hie-Won
    Scott, Fung
    Trinh, Huy
    Nguyen, Tuan Trong
    Paik, Seung Woon
    Gaggar, Anuj
    Flaherty, John
    Yee, Leland
    Jump, Belinda
    Sethi, Shalini
    Wu, George
    Chan, Carol Yee Kwan
    GUT, 2020, 69 : A73 - A74
  • [42] IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
    Chan, Henry Lik Yuen
    Lim, Young-Suk
    Seto, Wai Kay
    Ning, Qin
    Agarwal, Kosh
    Janssen, Harry L. A.
    Pan, Calvin O.
    Chuang, Wan Long
    Izumi, Namiki
    Fung, Scott
    Shalimar
    Brunetto, Maurizia
    Flaherty, John
    Mo, Shuyuan
    Cheng, Cong
    Lin, Lanjia
    Gaggar, Anuj
    Subramanian, Mani
    Marcellin, Patrick
    Gane, Edward
    Hou, Jinlin
    Buti, Maria
    GUT, 2020, 69 : A75 - A76
  • [43] FACTORS ASSOCIATED WITH A LACK OF VIRAL SUPPRESSION IN CHRONIC HBV ( CHB) PATIENTS AFTER 8 YEARS OF TREATMENT WITH TENOFOVIR ALAFENAMIDE ( TAF) OR TENOFOVIR DISOPROXIL FUMARATE ( TDF) FOLLOWED BY TAF TREATMENT
    Gane, Edward J.
    Buti, Maria
    Fung, Scott K.
    Chan, Henry Lik Yuen
    Izumi, Namiki
    Chuang, Wan Long
    Ahn, Sang Hoon
    Mehta, Rajiv M.
    Gurel, Selim
    Abramov, Frida
    Yee, Leland J.
    Wang, Hongyuan
    Mateo, Roberto
    Flaherty, John F.
    Ma, Xiaoli
    Pan, Calvin Q.
    Lim, Young-Suk
    Marcellin, Patrick
    HEPATOLOGY, 2023, 78 : S519 - S520
  • [44] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive patients with chronic hepatitis B
    Lim, Jihye
    Choi, Won-Mook
    Shim, Ju Hyun
    Lee, Danbi
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    JOURNAL OF HEPATOLOGY, 2022, 77 : S842 - S842
  • [45] No Detectable Resistance to Tenofovir Disoproxil Fumarate After 6 Years of Therapy in Patients With Chronic Hepatitis B
    Kitrinos, Kathryn M.
    Corsa, Amoreena
    Liu, Yang
    Flaherty, John
    Snow-Lampart, Andrea
    Marcellin, Patrick
    Borroto-Esoda, Katyna
    Miller, Michael D.
    HEPATOLOGY, 2014, 59 (02) : 434 - 442
  • [46] BONE AND RENAL SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 8 YEARS IN CHRONIC HBV ( CHB) PATIENTS WITH UNDERLYING RISK FACTORS FOR USE OF TENOFOVIR DISOPROXIL FUMARATE ( TDF)
    Buti, Maria
    Gane, Edward J.
    Agarwal, Kosh
    Wong, Grace Lai-Hung C.
    Lim, Young-Suk
    Chen, Chi-Yi
    Lim, Seng Gee
    Yatsuhashi, Hiroshi
    Fung, Scott K.
    Abramov, Frida
    Wang, Hongyuan
    Yee, Leland J.
    Flaherty, John F.
    Pan, Calvin Q.
    Marcellin, Patrick
    HEPATOLOGY, 2023, 78 : S507 - S509
  • [47] THREE YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBEAG-NEGATIVE AND POSITIVE PATIENTS WITH CHRONIC HEPATITIS B (STUDY 102 AND STUDY 103)
    Rizzetto, M.
    Marcellin, P.
    Heathcote, E. J.
    Sorbel, J.
    Mondou, E.
    Anderson, J.
    Rousseau, F.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S8 - S9
  • [48] IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
    Lim, Young-Suk
    Chan, Henry Lik Yuen
    Seto, Wai-Kay
    Ning, Qing
    Agarwal, Kosh
    Janssen, Harry L. A.
    Pan, Calvin Q.
    Chuang, Wan Long
    Izumi, Namiki
    Fung, Scott K.
    Shalimar
    Brunetto, Maurizia R.
    Flaherty, John F.
    Mo, Shuyuan
    Cheng, Cong
    Lin, Lanjia
    Gaggar, Anuj
    Subramanian, Mani
    Marcellin, Patrick
    Gane, Edward J.
    Hou, Jinlin
    Buti, Maria
    HEPATOLOGY, 2019, 70 : 126A - 127A
  • [49] No Detectable Resistance to Tenofovir Disoproxil Fumarate (TDF) in HBeAg plus and HBeAg- Patients with Chronic Hepatitis B (CHB) After Eight Years of Treatment
    Corsa, Amoreena C.
    Liu, Yang
    Flaherty, John F.
    Marcellin, Patrick
    Miller, Michael D.
    Kitrinos, Kathryn M.
    HEPATOLOGY, 2014, 60 : 1020A - 1020A
  • [50] Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naive Patients with Chronic Hepatitis B in Korea
    Kwon, Jung Hyun
    Song, Myeong Jun
    Jang, Jeong Won
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Kim, Hee Yeon
    Kim, Chang Wook
    Song, Do Seon
    Chang, U. Im
    Yang, Jin Mo
    You, Chan Ran
    Choi, Sang Wook
    Lee, Hae Lim
    Lee, Sung Won
    Han, Nam Ik
    Nam, Soon Woo
    Kim, Sang Gyune
    Kim, Young Seok
    Kim, Seok Hyun
    Lee, Byung Seok
    Lee, Tae Hee
    Cho, Eun-Young
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (07) : 2039 - 2048
12345